STAT

Congress revives ban on altering the DNA of human embryos used for pregnancies

Congress has revived a ban on altering the DNA of human embryos used for pregnancies, despite the objections of some scientists.
Rep. Robert Aderholt (R-Ala.)

A House committee on Tuesday restored to pending legislation a ban on altering the genomes of human embryos intended for pregnancies, despite calls from some scientists to lift the ban and allow the Food and Drug Administration to review applications for new technologies.

Lifting the prohibition could have opened the door to clinical trials of babies being made with genetic material from three people or with genomes that had been changed in ways that would be

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks